For young Indians grappling with aortic valve disease, the Ross procedure offers a lifeline—one that restores vitality ...

While 2023 and into 2024 might have been some of the most challenging times for Marinette’s Dan Buyarski and his health, ...

For patients with symptomatic aortic regurgitation at high surgical risk, a transcatheter aortic valve replacement system ...

The material is employed in a range of Edwards’ surgical and transcatheter valves, including versions of the Inspiris, Mitris ...

Transcatheter Aortic Valve Replacement Market outlook through 2035, highlighting key trends, growth drivers, challenges, and future opportunities ...

Edwards Lifesciences (NYSE: EW) today announced eight-year data highlighting positive long-term outcomes with its proprietary ...

Solo Pace announced today that it received FDA clearance for its SoloPace Control System for temporary pacing in TAVR ...

With surveillance, conversion to acute valve syndrome happened frequently and was linked to worse clinical outcomes.

After undergoing two open-heart surgeries in a year, a local elite runner is thanking the staff who saved him and is hoping ...

Dapagliflozin reduced the risk of death or worsening heart failure in older patients with aortic stenosis who underwent transcatheter aortic-valve implantation.

The replacement system is launching into markets already served by repair devices, namely Edwards’ Pascal and Abbott’s ...